Camillo Porta

24PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMetabolic medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jan 23, 2026
Identification of Predictive Genomic Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis of Real-World Clinicogenomic Data.

Mimma Rizzo, Gaetano Pezzicoli, Camilla Porta

|Nov 14, 2025
Two-Stage Estimation of Overall Survival in the Phase 3 CheckMate 9ER Trial, Adjusting for the Impact of Subsequent Therapy.

Marc-Oliver Grimm, Emma Karim, Venediktos Kapetanakis

|Mar 11, 2023
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies.

Valeria Internò, Maria Chiara Sergi, Maria Elvira Metta

|Sep 28, 2022
Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury.

Ben Sprangers, David E Leaf, Camillo Porta

|Jun 08, 2022
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®).

Caterina Caminiti, Jane Bryce, Silvia Riva

|May 28, 2022
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study.

Matteo Brunelli, Guido Martignoni, Giorgio Malpeli

Pageof 4

Frequent Collaborators

5 joint publications

Mimma Rizzo

3 joint publications

Pasquale Ditonno

3 joint publications

Giuseppe Lucarelli

2 joint publications

Juan Lucio Iovanna